In order to enhance the anti-tumor activity of T cells, Madiha Derouazi et al. used a CPP (Z12) to achieve cytoplasmic delivery of tumor antigens, which can then be processed and presented by MHC class I molecules, promoting persistent CD8+ T cells with strong cytotoxic function, extending survival in three robust tumor models [177]. This evidence concerns the gene CD8A and neoplasm.